|
MechanismAT III activators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date07 Dec 2000 |
100 Clinical Results associated with Ockham Biotech Ltd.
0 Patents (Medical) associated with Ockham Biotech Ltd.
100 Deals associated with Ockham Biotech Ltd.
100 Translational Medicine associated with Ockham Biotech Ltd.